Lu B
Cancer Pathog Ther. 2025; 3(1):16-29.
PMID: 39872371
PMC: 11764021.
DOI: 10.1016/j.cpt.2024.04.003.
Erickson A, Figiel S, Rajakumar T, Rao S, Yin W, Doultsinos D
PLoS One. 2025; 20(1):e0316475.
PMID: 39752458
PMC: 11698422.
DOI: 10.1371/journal.pone.0316475.
Hirsch M, Pal S, Rashidi Mehrabadi F, Malikic S, Gruen C, Sassano A
Cell Syst. 2024; 16(1):101156.
PMID: 39701099
PMC: 11867576.
DOI: 10.1016/j.cels.2024.11.013.
Weiner S, Bansal M
Life Sci Alliance. 2024; 8(3).
PMID: 39667913
PMC: 11638338.
DOI: 10.26508/lsa.202402923.
Johnston I, Diaz-Uriarte R
Bioinformatics. 2024; 41(1).
PMID: 39666947
PMC: 11681934.
DOI: 10.1093/bioinformatics/btae737.
Evolutionary rescue model informs strategies for driving cancer cell populations to extinction.
Dabi A, Brown J, Gatenby R, Jones C, Schrider D
bioRxiv. 2024; .
PMID: 39651238
PMC: 11623570.
DOI: 10.1101/2024.11.26.625315.
Integrative spatial and genomic analysis of tumor heterogeneity with Tumoroscope.
Shafighi S, Geras A, Jurzysta B, Sahaf Naeini A, Filipiuk I, Ra Czkowska A
Nat Commun. 2024; 15(1):9343.
PMID: 39472583
PMC: 11522407.
DOI: 10.1038/s41467-024-53374-3.
Resolving tumor evolution: a phylogenetic approach.
Li L, Xie W, Zhan L, Wen S, Luo X, Xu S
J Natl Cancer Cent. 2024; 4(2):97-106.
PMID: 39282584
PMC: 11390690.
DOI: 10.1016/j.jncc.2024.03.001.
HyperTraPS-CT: Inference and prediction for accumulation pathways with flexible data and model structures.
Aga O, Brun M, Dauda K, Diaz-Uriarte R, Giannakis K, Johnston I
PLoS Comput Biol. 2024; 20(9):e1012393.
PMID: 39231165
PMC: 11404842.
DOI: 10.1371/journal.pcbi.1012393.
Chromosome 7 Gain Compensates for Chromosome 10 Loss in Glioma.
Nair N, Schaffer A, Gertz E, Cheng K, Zerbib J, Sahu A
Cancer Res. 2024; 84(20):3464-3477.
PMID: 39078448
PMC: 11479827.
DOI: 10.1158/0008-5472.CAN-24-1366.
A Probabilistic Approach to Estimate the Temporal Order of Pathway Mutations Accounting for Intra-Tumor Heterogeneity.
Wang M, Xie Y, Liu J, Li A, Chen L, Stromberg A
Cancers (Basel). 2024; 16(13).
PMID: 39001551
PMC: 11240401.
DOI: 10.3390/cancers16132488.
Assessing the merits: an opinion on the effectiveness of simulation techniques in tumor subclonal reconstruction.
Lai J, Yang Y, Liu Y, Scharpf R, Karchin R
Bioinform Adv. 2024; 4(1):vbae094.
PMID: 38948008
PMC: 11213631.
DOI: 10.1093/bioadv/vbae094.
Oncotree2vec - a method for embedding and clustering of tumor mutation trees.
Baciu-Dragan M, Beerenwinkel N
Bioinformatics. 2024; 40(Suppl 1):i180-i188.
PMID: 38940124
PMC: 11211817.
DOI: 10.1093/bioinformatics/btae214.
Stochastic modelling of single-cell gene expression adaptation reveals non-genomic contribution to evolution of tumor subclones.
Hirsch M, Pal S, Rashidi Mehrabadi F, Malikic S, Gruen C, Sassano A
bioRxiv. 2024; .
PMID: 38712152
PMC: 11071284.
DOI: 10.1101/2024.04.17.588869.
A seven-step guide to spatial, agent-based modelling of tumour evolution.
Colyer B, Bak M, Basanta D, Noble R
Evol Appl. 2024; 17(5):e13687.
PMID: 38707992
PMC: 11064804.
DOI: 10.1111/eva.13687.
CINner: modeling and simulation of chromosomal instability in cancer at single-cell resolution.
Dinh K, Vazquez-Garcia I, Chan A, Malhotra R, Weiner A, McPherson A
bioRxiv. 2024; .
PMID: 38617259
PMC: 11014621.
DOI: 10.1101/2024.04.03.587939.
Marker selection strategies for circulating tumor DNA guided by phylogenetic inference.
Fu X, Luo Z, Deng Y, LaFramboise W, Bartlett D, Schwartz R
bioRxiv. 2024; .
PMID: 38586041
PMC: 10996527.
DOI: 10.1101/2024.03.21.585352.
A review of mechanistic learning in mathematical oncology.
Metzcar J, Jutzeler C, Macklin P, Kohn-Luque A, Bruningk S
Front Immunol. 2024; 15:1363144.
PMID: 38533513
PMC: 10963621.
DOI: 10.3389/fimmu.2024.1363144.
Impact of Resistance on Therapeutic Design: A Moran Model of Cancer Growth.
Lacy M, Jenner A
Bull Math Biol. 2024; 86(4):43.
PMID: 38502371
PMC: 10950993.
DOI: 10.1007/s11538-024-01272-6.
Evaluation of simulation methods for tumor subclonal reconstruction.
Lai J, Liu Y, Scharpf R, Karchin R
ArXiv. 2024; .
PMID: 38410652
PMC: 10896360.